AgakuITAyo-YusufOAVardavasCI. 2014. A comparison of cessation counseling received by current smokers at US dentist and physician offices during 2010–2011. Am J Public Health. 104(8):e67–e75.
2.
AghalooTKimJJGordonTBehrsingHP. 2019. In vitro models, standards, and experimental methods for tobacco products. Adv Dent Res. 30(1):16–21.
3.
American Association for Dental Research. 2016. Comment from American Association for Dental Research. Alexandria (VA): American Association for Dental Research; [accessed 2019 March]. https://www.regulations.gov/document?D=FDA-2016-D-2495-0007.
AndrewsJASeversonHHLichtensteinEGordonJSBarckleyMF. 1999. Evaluation of a dental office tobacco cessation program: effects on smokeless tobacco use. Ann Behav Med. 21(1):48–53.
CarpenterKMCarliniBHPainterIMikkoATStonerSA. 2012. Refer2Quit: impact of web-based skills training on tobacco interventions and quitline referrals. J Contin Educ Health Prof. 32(3):187–195.
8.
CarrABEbbertJ. 2012. Interventions for tobacco cessation in the dental setting. Cochrane Database Syst Rev. (6):CD005084.
9.
CullenKAAmbroseBKGentzkeASApelbergBJJamalAKingBA. 2018. Use of electronic cigarettes and any tobacco product among middle and high school students—United States, 2011–2018. Morb Mortal Wkly Rep. 67(45):1276–1277.
10.
DaneshDPaskettEDFerketichAK. 2014. Disparities in receipt of advice to quit smoking from health care providers: 2010 National Health Interview Survey. Prev Chronic Dis. 11:E131.
11.
DavisJMArnettMRLoewenJRomitoLGordonSC. 2016. Tobacco dependence education: a survey of US and Canadian dental schools. J Am Dent Assoc. 147(6):405–412.
12.
DrouinOMcMillenRCKleinJDWinickoffJP. 2018. E-cigarette advice to patients from physicians and dentists in the United States. Am J Health Promot. 32(5):1228–1233.
13.
FarrellyMCDukeJCNonnemakerJMacMonegleAJAlexanderTNZhaoXDelahantyJCRaoPAllenJA. 2017. Association between the Real Cost Media Campaign and smoking initiation among youths—United States, 2014–2016. Morb Mortal Wkly Rep. 66(2):47–50.
Food and Drug Administration, US Department of Health and Human Services. 2016. Deeming tobacco products to be subject to the federal Food, Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act; restrictions on the sale and distribution of tobacco products and required warning statements for tobacco products. Fed Regist. 81:28973–29106.
17.
Food and Drug Administration, US Department of Health and Human Services. 2017. Tobacco product standard for n-nitrosonornicotine level in finished smokeless tobacco products. Fed Regist. 82:8004–8053.
18.
Food and Drug Administration, US Department of Health and Human Services. 2018. Tobacco product standard for nicotine level of combusted cigarettes. Fed Regist. 83:11818–11843.
19.
GanskySAEllisonJARudyDBergertNLetendreMANelsonLKavanaghCWalshMM. 2005. Cluster-randomized controlled trial of an athletic trainer-directed spit (smokeless) tobacco intervention for collegiate baseball athletes: results after 1 year. J Athl Train. 40(2):76–87.
20.
GiovinoGAVillantiACMoweryPDSevilimeduVNiauraRSValloneDMAbramsDB. 2015. Differential trends in cigarette smoking in the USA: is menthol slowing progress?Tob Control. 24(1):28.
21.
GordonJSAndrewsJAAlbertDACrewsKMPayneTJSeversonHH. 2010. Tobacco cessation via public dental clinics: results of a randomized trial. Am J Public Health. 100(7):1307–1312.
22.
GordonJSMerianosAL. 2018. Tobacco cessation counseling received by current smokers in healthcare settings: results from the 2015 National Health Interview Survey. Forthcoming.
GottliebSZellerM. 2017. A nicotine-focused framework for public health. N Engl J Med. 377(12):1111–1114.
25.
HoffmanACSalgadoRVDreslerCFallerRWBartlettC. 2016. Flavour preferences in youth versus adults: a review. Tob Control. 25 Suppl 2:ii32.
26.
International Agency for Research on Cancer. 2007. IARC monographs on the evaluation of carcinogenic risks to humans: smokeless tobacco and some tobacco-specific n-nitrosamines. Lyon (France): World Health Organization.
27.
JacobM. 2019. Looking back and ahead: the Food and Drug Administration’s regulation of the tobacco industry and next-generation products. Adv Dent Res. 30(1):22–25.
28.
KottkeTEBrad RindalDRushWAAscheSEEnstadCJ. 2015. Persistence of smoking-cessation decision support use in a dental practice. Am J Prev Med. 48(6):722–728.
MacMonegleAJNonnemakerJDukeJCFarrellyMCZhaoXDelahantyJCSmithAARaoPAllenJA. 2018. Cost-effectiveness analysis of the Real Cost Campaign’s effect on smoking prevention. Am J Prev Med. 55(3):319–325.
31.
MartinEGWarnerKELantzPM. 2004. Tobacco harm reduction: what do the experts think?Tob Control. 13(2):123.
32.
McDanielPASmithEAMaloneRE. 2016. The tobacco endgame: a qualitative review and synthesis. Tob Control. 25(5):594.
33.
McNeillABroseLCalderRBauldLRobsonD. 2018. Evidence review of e-cigarettes and heated tobacco products 2018: a report commissioned by Public Health England. London (UK): Public Health England.
34.
National Academies of Sciences, Engineering, and Medicine.2018. Public health consequences of e-cigarettes. Washington (DC): The National Academies Press.
PeetersSGilmoreAB. 2015. Understanding the emergence of the tobacco industry’s use of the term tobacco harm reduction in order to inform public health policy. Tob Control. 24(2):182.
37.
RamseierCABurriMBerresFDavisJM. 2013. The implementation of a tobacco dependence education curriculum in a Swiss dental hygiene school—an 8-year review. Int J Dent Hyg. 11(2):142–150.
38.
RayMNFunkhouserEWilliamsJHSadasivamRSGilbertGHColeyHLRindalDBHoustonTK. 2014. Smoking-cessation e-referrals: a national dental practice-based research network randomized controlled trial. Am J Prev Med. 46(2):158–165.
39.
RindalDBRushWASchleyerTKKirshnerMBoyleRGThoeleMJAscheSEThyvalikakathTSpallekHDurandECet al. 2013. Computer-assisted guidance for dental office tobacco-cessation counseling: a randomized controlled trial. Am J Prev Med. 44(3):260–264.
40.
SadasivamRSHoganTPVolkmanJESmithBMColeyHLWilliamsJHDelaughterKRayMNGilbertGHFordDEet al. 2013. Implementing point of care “e-referrals” in 137 clinics to increase access to a quit smoking internet system: the Quit-Primo and National Dental PBRN HI-QUIT Studies. Transl Behav Med. 3(4):370–378.
41.
SeversonHHPetersonALAndrewsJAGordonJSCigrangJADanaherBGHunterCMBarckleyM. 2009. Smokeless tobacco cessation in military personnel: a randomized controlled trial. Nicotine Tob Res. 11(6):730–738.
42.
TsaiJWaltonKColemanBNSharapovaSRJohnsonSEKennedySMCaraballoRS. 2018. Reasons for electronic cigarette use among middle and high school students—National Youth Tobacco Survey, United States, 2016. Morb Mortal Wkly Rep. 67:196–200.
43.
TomarSL. 2019. Oral health effects of tobacco products: science and regulatory policy. Adv Dent Res. 30(1):2–3.
44.
TomarSLHechtSSJaspersIGregoryRLStepanovI. 2019. Oral health effects of combusted and smokeless tobacco products. Adv Dent Res. 30(1):4–10.
45.
US Department of Health and Human Services. 2004. Other effects: the health consequences of smoking: a report of the Surgeon General. Atlanta, GA: Deptartment of Health and Human Services. p. 732–736.
46.
US Department of Health and Human Services. 2016. E-cigarette use among youth and young adults: a report of the surgeon general. Atlanta, GA: US Department of Health and Human Services.
47.
WalkerMWEvansSAWimpyCBergerATSmithAA. 2018. Developing smokeless tobacco prevention messaging for at-risk youth: early lessons from “The Real Cost” Smokeless Campaign. Health Equity. 2(1):167–173.
48.
WalshMMRankinKVSilvermanSJr.2013. Influence of continuing education on dental hygienists’ knowledge and behavior related to oral cancer screening and tobacco cessation. J Dent Hyg. 87(2):95–105.
49.
WangTWAsmanKGentzkeASCullenKAHolder-HayesEReyes-GuzmanCJamalANeffLKingBA. 2018. Tobacco product use among adults—United States, 2017. Morb Mortal Wkly Rep. 67(44):1225–1232.
50.
WilsonMKarkiAJGouldA. 2016. Evaluation of the Stop Smoking Wales NHS dental practice incentive scheme. Br Dent J. 221(11):731–735.
